XML 39 R26.htm IDEA: XBRL DOCUMENT v3.23.2
Segmentation of key figures - Net sales by segment and Consolidated income statements (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Disclosure of operating segments [line items]        
Net sales to third parties $ 2,402 $ 2,200 $ 4,735 $ 4,375
Other revenues 20 17 39 31
Net sales and other revenues 2,422 2,217 4,774 4,406
Total segment contribution 581 495 1,161 1,037
Amortization of intangible assets (187) (162) (377) (324)
Impairment charges on intangible assets 0 (61) 0 (61)
General & administration (corporate) (74) (70) (142) (132)
Transformation costs (26) (9) (52) (24)
Fair value adjustments to contingent consideration liabilities 0 7 0 7
Integration related costs (8) (4) (14) (9)
Other (16) 4 (38) (48)
Operating income 270 200 538 446
Interest expense (48) (31) (95) (60)
Other financial income & expense (9) (22) (17) (39)
Income before taxes 213 147 426 347
Surgical        
Disclosure of operating segments [line items]        
Net sales to third parties 1,382 1,296 2,686 2,555
Total segment contribution 407 348 788 720
Surgical | Implantables        
Disclosure of operating segments [line items]        
Net sales to third parties 437 444 864 899
Surgical | Consumables        
Disclosure of operating segments [line items]        
Net sales to third parties 714 644 1,370 1,245
Surgical | Equipment/other        
Disclosure of operating segments [line items]        
Net sales to third parties 231 208 452 411
Vision Care        
Disclosure of operating segments [line items]        
Net sales to third parties 1,020 904 2,049 1,820
Total segment contribution 174 147 373 317
Vision Care | Contact lenses        
Disclosure of operating segments [line items]        
Net sales to third parties 594 547 1,209 1,104
Vision Care | Ocular health        
Disclosure of operating segments [line items]        
Net sales to third parties $ 426 $ 357 $ 840 $ 716